Counterfeit Drugs : A CLEAR AND PRESENT DANGER State Senator Marvin Riegsecker, R.Ph.

Slides:



Advertisements
Similar presentations
Our role in the U.S. pharmaceutical supply chain:
Advertisements

Issues and Compliance Strategies Related to Government Pricing Joseph W. Metro.
الرابطة الدولية لمكافحة المواد الطبيّة المزورة a WHO initiative to combat counterfeit medical products Dr V. Reggi - World Health Organization.
Copyright of the Health Sciences Authority 2007 ASEAN-China Conference on Combating Counterfeit Medical Products Jakarta, November 2007 Singapore.
IMPACT REGIONAL CONFERENCE ON COMBATING COUNTERFEIT MEDICAL PRODUCT: 9-10 NOVEMBER 2009: KEMPTON PARK,SOUTH AFRICA: BY DETECTIVE INSPECTOR NAMIBIA.
WHO Good Distribution Practices for Pharmaceutical Products
First ASEAN-China Conference on Combating Counterfeit Medical Products Jakarta November 2007 CHOO CHEOK HANG DEPARTMENT OF PHARMACEUTICAL SERVICES.
DG Enterprise and Industry Approach on Combating Counterfeit Medicines Council of Europe Conference “Europe against Counterfeit Medicines” Session: Key.
Track and Trace PSSNY 2015 Mid-Winter Conference Al Emmans
Practicum of Health Science Class. The signature on a class-II written prescription A. may be stamped B. may be made by prescriber’s agent C. must be.
WA 2.ID 3.MT 4.OR 5.CA 6.NV 7.UT 8.WY 9.CO 10.AZ 11.NM 12.AK 13.HI 13 The West`
CLIA-Waiver What is CLIA?
U.S. Drug Supply Chain Integrity: Protecting Patient Safety CDR Connie Jung, PharmD, PhD LCDR Eleni Anagnostiadis, RPh Office of Drug Security, Integrity,
Counterfeit Medicines and Fight against Counterfeit Medicines.
Strengthening the Protection of Intellectual and Industrial Property Rights Deputy Manager Jan Hylleberg The Danish Association of the Pharmaceutical Industry.
MeTa, Solwezi 27 August,2013.  A branded- name drug product is originally discovered and developed by a pharmaceutical company.  Branded-name drugs.
ILISA B.G. BERNSTEIN, PHARM.D., J.D. U.S. Food and Drug Administration
Reforming State Long-Term Care Services and Supports Through Participant Direction NASHP State Health Policy Conference October 2010 Suzanne Crisp Director.
Combined Internal Medicine-Pediatrics Match 2013 and other Data Allen Friedland, MD, FACP, FAAP.
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
BUS 590 O: Biotech and Pharma Law Professor David Baumer Fall, 2006.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Pedigree Laws and their Impact on the Animal Health Industry Annual Update Randy Lewis MWI Veterinary Supply Co. Manager of Compliance & Regulatory Affairs.
Cross-Border Internet Pharmacy: Why are they so dangerous? Louise Binder, Chair Canadian Treatment Action Council.
Pharmaceutical Drug Abuse Counterfeit Drugs. Current State of Affairs National drug prevalence studies indicate a sharp increase in prescription drug.
Hoyt J. Burdick, MD, FACP, FCCP Previous WVSMA President WV OMSS Chair AMA Alternate Delegate.
Copyright 2015 © HSI, LLC. All rights reserved. (949)
Pharmacy Regulatory Updates and an Introduction to Specialty Pharmacy
1 Copyright © 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 2 Pharmacy Law, Standards and Ethics for Technicians.
Ways and means of improving the effectiveness of the system of state regulation of trade in medicines R.U.Khabriev Head of the Federal Inspectorate for.
Communication is the Key Pharmacy Purchasing Pearls Marvin Finnefrock, PharmD Steven L. Gratch, Pharm. B.Sc., R.Ph. Diane Daskey Joanie MacIntosh, CPhT.
Saving Lives, Saving Money Lilia Bounab – Healthcare Sales Manager EMEA Ar ł amów hotel, 14-16th June 2015.
Illegal Gun Policy in the United States: Federal Gaps and State Legislative Contrasts Nina E. Vinik Legal Community Against Violence.
Licensing conditions of realisation economic activities of manufacture, wholesale and retail trade in medical products.
1 Good Intentions – Bad Drugs Washington, DC Thursday, 10 March 2005 Robert D. Moore, Executive Director; Global Security Group Merck & Co., Inc.
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
Consumer Protection Laws in Casinos June 6, 2014 Jonathan Griffin Fiscal Affairs Program.
Quality & Safety of Generic Drugs in the World Market World Bank Conference “Good Intentions – Bad Drugs” March 10, 2005 Washington, D.C. Christine Simmon.
Medical Products & Samples Thomas Hazlet, PhPH, PharmD.
INTRODUCTION AND OBJECTIVES LEGAL ASPECTS AND SOCIO-ECONOMIC IMPLICATIONS REGARDING DRUG COUNTERFEITING CIOBANU CONSTANTIN, CORCIOVĂ ANDREIA Faculty of.
Barth Syndrome Registry July 29, 2010 Carolyn Spencer, MD and Amy E. Roberts, MD Children’s Hospital Boston.
By: Drew Perry. Counterfeit pharmaceutical drugs are fraudulently produced or mislabeled medicines purchased by consumers who believe them to be legitimate.
PHARMACY LAWS.
2003 Casualty Actuary Society State Regulatory Update Insurance Scoring.
Department of Energy’s Energy and Employment Report Breakdown of Industrial Sub-Sector Employment, Job Growth Trends, Geographic Spread and More April.
“Understanding the New Paradigms in Pharmacy Compliance with Proper Drug Distribution” Drug Supply Chain Security Act (Title II of the Drug Quality and.
Veterinary Products Management and Quality Control System in Thailand : Veterinary Vaccine Tasanee Lorchaivej Workshop on the Veterinary Products.
1 Special mechanism for the importation of pharmaceutical products under the TRIPS Agreement Carlos M. Correa.
Inventory Management Chapter 13.
Global Marketing Review
Mark Glerum – Sales Director
Existing laws requiring abortion clinics to meet surgical center standards and require abortion providers to have hospital privileges WY WIǂ WV WA VA VT.
Safe Online Pharmacies
An Increasing Demand for Prescription Drugs Drives Profitability
National Pharmacy Practice Standards the Regulatory Role
Influenza Vaccine Distribution
State Health Insurance Marketplace Types, 2015
State Health Insurance Marketplace Types, 2018
CA Compliance Law: Challenges for Industry
Sampling Distribution of a Sample Mean
Current Status of State Medicaid Expansion Decisions
State Health Insurance Marketplace Types, 2017
Current Status of State Medicaid Expansion Decisions
Employer Premiums as Percentage of Median Household Income for Under-65 Population, 2003 and percent of under-65 population live where premiums.
Employer Premiums as Percentage of Median Household Income for Under-65 Population, 2003 and percent of under-65 population live where premiums.
Average annual growth rate
Sampling Distribution of a Sample Mean
Rebecca Snead Executive Vice President & CEO NASPA
Employer Premiums as Percentage of Median Household Income for Under-65 Population, 2003 and percent of under-65 population live where premiums.
Compounded Drugs and Lack of Premarket FDA-Approval
Presentation transcript:

Counterfeit Drugs : A CLEAR AND PRESENT DANGER State Senator Marvin Riegsecker, R.Ph.

Prevalence of Drug Counterfeiting Counterfeit drugs are more prevalent in developing countries. According to the World Health Organization (WHO): A. Industrialized Countries: 22% B. Developing Countries: 78% Africa: 50-60% China: 50% Mexico, Argentina, Columbia: 40% Brazil: 30-40% India: 15-20%

Trends in Counterfeit Drug Cases Number of open FDA Cases

What is a Counterfeit Drug? According to WHO: “[A] product that is deliberately and fraudulently mislabeled with respect to identity and source.”

Where is the problem? Drug counterfeiting isn’t a manufacturing problem, it is a distribution problem.

Red arrows indicate secondary (gray) market

Example 1: Lipitor According to WHO: “ [A] product that is deliberately and fraudulently mislabeled with respect to identity and source.”

Lipitor: Which pill is authentic?

Epogen Trail to Timothy Fagan AmerisourceBergen 3,363 boxes 2,000 U/mL J&M Pharmacare FL Pharmacy Bought 12,294 boxes 2,000 U/mL Cardinal 8,931boxes 2,000 U/mL Amgen Drugmaker 2,000 U/mL Armando Rodriguez FL Go-between 12,294 boxes 2,000 U/mL Playpen South FL Strip Club Nick Just/ Paul Perito Tradewinds Trading TX Wholesaler 135 Boxes Lot 2970 Rebel Dist CA Wholesaler Grapevine Trading OH Wholesaler Coastal Medical VA Wholesaler 135 Boxes Lot 2970 AD Pharmaceutical FL Wholesaler 2 Boxes Lot 2970 Medix Intl Carlos Luis TX Shell Co. 180 Boxes Lot 2970 Armin Medical 24 Nashua, NH 129 Boxes Lot 2970 Premier Medical Group GA Shell Co. 460 Boxes Lot Boxes Lot 2970 Express RX Eddie Mor Texas Shell Co. 180 Boxes Lot 2970 Y W Consultants Unlicensed FL Wholesaler Double J Unlicensed FL Wholesaler Ivan Villarchao FL 45 Boxes Lot 2970 CSG TN Wholesaler 460 Boxes Lot 1091 AmeRx Susan Cavalieri FL Wholesaler 182 Boxes Lot 2970 CSG TN Wholesaler 812 Boxes Lot 2970 Optia Medical Mark Novosel UT Shell Co. 45 Boxes Lot 2970 Jemco Medical FL Wholesaler 16 Boxes Lot 2970 Dialysist West AZ Wholesaler 461 Boxes, Lot 1091 Dialysist West AZ Wholesaler 1056 Boxes, Lot 2970 AmerisourceBergen KY Distribution Center 1517 Boxes Timothy Fagan CVS, NY MANUFACTURER NATIONAL WHOLESALER PHARMACY GRAY MARKET REGIONAL WHOLESALER NATIONAL WHOLESALER PHARMACY PATIENT probable sales unknown sources and sales confirmed sales Silvino Cristobal Morales Relabeled Vials Printer in Hialeah Made Counterfeit Labels Jose Grillo Alleged FL Counterfeiter 2,000 U/mL  40,000 U/mL Example 2: Epogen

Example 3: Tamiflu Fighting Fake Flu Pills

What can be done? Federal Regulation of Wholesale Distributors: Prescription Drug Marketing Act (PDMA) of 1987, Prescription Drug Amendments (PDA) of 1992 Banned the Sale of Drug Samples and Drug Coupons Banned Reimportation (limited exceptions) Set Requirements for Sample Distribution and Storage Required State Licensing of Wholesale Distributors Required Identity Statements for Sales (pedigree) by Unauthorized Distributors of Record

What can be done? State Licensing of Wholesale Distributors: State Boards of Pharmacy Renewal Schedule: One to Two years Out-of-State Wholesale Distributors Regulatory Challenges Limited Board of Pharmacy Resources Lack of Uniformity of States’ Regulation Lack of Communication Between Regulators

Indiana’s New WDD Law Increases penalties for counterfeiting Rx drugs and distributing contraband drugs Creates rigorous licensing requirements including mandatory accreditation for all wholesalers Determines a “Normal Chain of Distribution” (NCOD) Requires pedigree for all drugs distributed outside of NCOD

Indiana’s New WDD Law Mandatory National Accreditation VAWD® or other Board Approved Accreditation Accreditation will ensure compliance with relevant state and federal laws Newly issued licensees must obtain Accreditation prior to issuance Existing license holders must obtain prior to next license renewal ( 9/30/06) Negligible fiscal and operational impact on state